HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 3 (2006), Issue 11 (November)

1. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
   Cancer Sci, 97(12): 1381-7. [Abstract] [Full-text]
2. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
   Clin Infect Dis, 43(11): 1482-9. [Abstract] [Full-text]
3. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
   Clin Infect Dis, 43(11): 1476-81. [Abstract] [Full-text]
4. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.
   Lancet, 368(9547): 1587-94. [Abstract] [Full-text]
5. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
   Lancet, 368(9547): 1575-80. [Abstract] [Full-text]
6. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
   J Biol Chem, 281(45): 34574-91. [Abstract] [Full-text]
7. AIDS: caused by development of resistance to drugs in a non-target intracellular parasite.
   Med Hypotheses, 68(1): 151-7. [Abstract] [Full-text]
8. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
   Proc Natl Acad Sci U S A, 103(45): 16959-64. [Abstract] [Full-text]
9. Synthesis and anti-HIV properties of new hydroxyquinoline-polyamine conjugates on cells infected by HIV-1 LAV and HIV-1 BaL viral strains.
   Bioorg Med Chem Lett, 16(23): 5988-92. [Abstract] [Full-text]
10. Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.
    Retrovirology, 3: 79. [Abstract] [Full-text]
11. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    J Infect, 53(6): 357-63. [Abstract] [Full-text]
12. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.
    Vaccine, 24(49): 7124-8. [Abstract] [Full-text]
13. Changes in clinician ability to assess risk and help patients determine the need for hiv testing: a comparison of three teaching methods.
    Eval Health Prof, 29(4): 367-93. [Abstract] [Full-text]
14. Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity.
    Biochem Biophys Res Commun, 351(3): 664-8. [Abstract] [Full-text]
15. Early dysregulation of cripto-1 and immunomodulatory genes in the cerebral cortex in a macaque model of neuroAIDS.
    Neurosci Lett, 410(2): 94-9. [Abstract] [Full-text]
16. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana.
    Clin Infect Dis, 43(12): 1612-5. [Abstract] [Full-text]
17. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
    J Gen Intern Med, 21(12): 1235-41. [Abstract] [Full-text]
18. Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.
    Retrovirology, 3: 82. [Abstract] [Full-text]
19. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Retrovirology, 3: 81. [Abstract] [Full-text]
20. Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data.
    Lancet, 368(9549): 1788-93. [Abstract] [Full-text]
21. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma.
    Blood, 108(12): 3871-80. [Abstract] [Full-text]
22. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
    Blood, 108(12): 3786-91. [Abstract] [Full-text]
23. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.
    Blood, 108(12): 3808-17. [Abstract] [Full-text]
24. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.
    Blood, 108(12): 3834-42. [Abstract] [Full-text]
25. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
    CMAJ, 175(11): 1399-404. [Abstract] [Full-text]
26. HIV-1 subtype A infection in a community of intravenous drug users in Pakistan.
    BMC Infect Dis, 6: 164. [Abstract] [Full-text]
27. Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products.
    Retrovirology, 3: 80. [Abstract] [Full-text]
28. Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.
    BMC Infect Dis, 6: 159. [Abstract] [Full-text]
29. Effectiveness of an HIV prevention program for secondary school students in Mongolia.
    J Adolesc Health, 39(6): 925.e9-16. [Abstract] [Full-text]
30. Evaluation of a school-based HIV/AIDS educational intervention in Ukraine.
    J Adolesc Health, 39(6): 900-7. [Abstract] [Full-text]
31. Structural studies on the RNA-recognition motif of NELF E, a cellular negative transcription elongation factor involved in the regulation of HIV transcription.
    Biochem J, 400(3): 449-56. [Abstract] [Full-text]
32. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Antimicrob Agents Chemother, 50(12): 4005-10. [Abstract] [Full-text]
33. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.
    Antimicrob Agents Chemother, 50(12): 4182-5. [Abstract] [Full-text]
34. In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.
    Antimicrob Agents Chemother, 50(12): 4087-95. [Abstract] [Full-text]
35. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.
    BMC Infect Dis, 6: 160. [Abstract] [Full-text]
36. Victimization, substance use, and HIV risk behaviors among gay/bisexual/two-spirit and heterosexual American Indian Men in New York City.
    Am J Public Health, 96(12): 2240-5. [Abstract] [Full-text]
37. Progress and obstacles in the development of an AIDS vaccine.
    Nat Rev Immunol, 6(12): 930-9. [Abstract] [Full-text]
38. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology.
    Neurobiol Dis, 25(1): 17-26. [Abstract] [Full-text]
39. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Eur J Public Health, 16(6): 601-8. [Abstract] [Full-text]
40. Fighting tuberculosis and HIV/AIDS in Northeast Europe: sustainable collaboration or political rhetoric?
    Eur J Public Health, 16(6): 609-14. [Abstract] [Full-text]
41. Diminished somatostatin gene expression in individuals with HIV and major depressive disorder.
    Neurology, 67(10): 1867-9. [Abstract] [Full-text]
42. Syphilis among female sex workers in southwestern China: potential for HIV transmission.
    Sex Transm Dis, 33(12): 719-23. [Abstract] [Full-text]
43. Substance use, medications for sexual facilitation, and sexual risk behavior among traveling men who have sex with men.
    Sex Transm Dis, 33(12): 706-11. [Abstract] [Full-text]
44. Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs.
    J Immigr Minor Health, 9(1): 49-54. [Abstract] [Full-text]
45. Bacteraemia in severely malnourished children in an HIV-endemic setting.
    Ann Trop Paediatr, 26(4): 319-28. [Abstract] [Full-text]
46. CD4+ count-guided interruption of antiretroviral treatment.
    N Engl J Med, 355(22): 2283-96. [Abstract] [Full-text]
47. Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors.
    Prep Biochem Biotechnol, 37(1): 1-11. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.